Cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alfaxalone in dogs.
暂无分享,去创建一个
Laura L. Nelson | T. Whittem | W. Muir | K. Pasloske | A. Wiese | P. Lerche
[1] T. Whittem,et al. Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU. , 2006, Veterinary anaesthesia and analgesia.
[2] P. Pascoe,et al. Reference cardiopulmonary values in normal dogs. , 2005, Comparative medicine.
[3] W. Muir,et al. Effect of medetomidine on breathing and inspiratory neuromuscular drive in conscious dogs. , 2004, American journal of veterinary research.
[4] J. A. Peters,et al. Neurosteroid modulation of GABAA receptors , 2003, Progress in Neurobiology.
[5] C. Goodchild,et al. Antinociceptive properties of neurosteroids I. Spinally-mediated antinociceptive effects of water-soluble aminosteroids , 2000, Pain.
[6] C. Goodchild,et al. Antinociceptive properties of neurosteroids II. Experiments with Saffan® and its components alphaxalone and alphadolone to reveal separation of anaesthetic and antinociceptive effects and the involvement of spinal cord GABAA receptors , 2000, Pain.
[7] W. Muir,et al. Respiratory depression and apnea induced by propofol in dogs. , 1998, American journal of veterinary research.
[8] J. Sear. Steroid anesthetics: old compounds, new drugs. , 1996, Journal of clinical anesthesia.
[9] W. R. Lieb,et al. Molecular and cellular mechanisms of general anaesthesia , 1994, Nature.
[10] R. M. Joy,et al. Modification of GABA-mediated inhibition by various injectable anesthetics. , 1992, Anesthesiology.
[11] M. Brewster,et al. An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys , 1990 .
[12] A. Suria,et al. GABA involvement in naloxone induced reversal of respiratory paralysis produced by thiopental. , 1988, Life sciences.
[13] P. Pascoe,et al. Effects of saffan on cardiopulmonary function in healthy cats. , 1987, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[14] F. Ferracci,et al. Ventilatory effects of oxygen-enriched mixtures in the dog under althesin anaesthesia. , 1986, British journal of anaesthesia.
[15] R. Jones. HYPOXIC VENTILATORY DRIVE IN THE DOG UNDER ALTHESIN ANAESTHESIA , 1985 .
[16] J. Ilkiw,et al. Physiological effects of thiopentone, ketamine and CT 1341 in cats. , 1982, Research in veterinary science.
[17] P. Korner,et al. Role of baroreceptor reflexes in the hemodynamic and heart rate responses to althesin, ketamine and thiopentone anesthesia. , 1981, Journal of the autonomic nervous system.
[18] D. Brown,et al. Adverse responses to i.v. anaesthetics. , 1981, British journal of anaesthesia.
[19] J. Sear,et al. Steroid anaesthesia , 1992, Lancet.
[20] Haskins Sc,et al. A clinical comparison of CT1341, ketamine, and xylazine in cats. , 1975 .
[21] K. J. Child,et al. Anaesthetic, cardiovascular and respiratory effects of a new steroidal agent CT 1341: a comparison with other intravenous anaesthetic drugs in the unrestrained cat , 1972, British journal of pharmacology.
[22] T. M. Savege,et al. A comparison of the cardiorespiratory effects during induction of anaesthesia of Althesin with thiopentone and methohexitone. , 1972, Postgraduate medical journal.
[23] J. Evans,et al. Clinical evaluation in cats of a new anaesthetic, CT 1341. , 1972, The Journal of small animal practice.
[24] J. P. Currie,et al. THE PHARMACOLOGICAL PROPERTIES IN ANIMALS OF CT1341—A NEW STEROID ANAESTHETIC AGENT , 1972, British journal of anaesthesia.
[25] T. Lawrie,et al. A PRELIMINARY CLINICAL STUDY OF CT1341— A STEROID ANAESTHETIC AGENT , 1972, British journal of anaesthesia.
[26] H. Selye. STUDIES CONCERNING THE ANESTHETIC ACTION OF STEROID HORMONES , 1941 .